Neurology Letters
Is There a Need to Differentiate Atypical Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorders (NMOSD)? The Pros and Cons: A Systematic Review (PP-21)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Sepideh Paybast; Fatemeh Baghalha; Ali Emami; Abdorreza Naser Moghadasi
Lingual dystonia as the first manifestation of multiple sclerosis (PP-22)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Farid Shamlou
MS and exercise (PP-23)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Maryam Abolhasani; Farzin Halabchi
Multidisciplinary rehabilitative management (PP-24)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Razieh Pirzad
Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Fardin Nabizadeh; Elham Ramezannezhad; Kimia Kazemzadeh; Elham Khalili; Elham Moases Ghaffary; Omid Mirmosayyeb
Neurosarcoidosis in an adult man with a family history of MS: A Case report (PP-26)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Elham Sadat Azimi
Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Farinaz Tabibian; Kiarash Azimzadeh; Vahid Shaygannejad; Fereshteh Ashtari; Iman Adibi; Mehdi Sanayei
Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: A cross-sectional case-control study (PP-28)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Amir Ali Gharemani
Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mohammad Yazdan Panah; Saeed Vaheb; Yousef Mokary; Elham Moases Ghaffary; Alireza Afshari-Safavi; Aysa Shaygannejad; Narges Ebrahimi; Vahid Shaygannejad; Omid Mirmosayyeb
Pharmacogenomics of Multiple Sclerosis: Sieving treatment biomarkers from blood gene-expression profiles (PP-30)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Maryam Mohaghegh; Mohammad Hossein Sanati; Mitra Ataei; Mehdi Sadeghi; Shokoufeh Alayi
)